TY - JOUR
T1 - Transcriptional Events during the Recovery from MRSA Lung Infection
T2 - A Mouse Pneumonia Model
AU - Chen, Jiwang
AU - Feng, Gang
AU - Guo, Qiang
AU - Wardenburg, Juliane B.
AU - Lin, Simon
AU - Inoshima, Ichiro
AU - Deaton, Ryan
AU - Yuan, Jason X.J.
AU - Garcia, Joe G.N.
AU - Machado, Roberto F.
AU - Otto, Michael
AU - Wunderink, Richard G.
N1 - Funding Information:
This project was supported by Pfizer Inc. The authors state that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials. All the coauthors, except Dr. Richard Wunderink, have declared that there is not any potential competing interest. Dr. Richard Wunderink supplied the following declaration: "Dr. Wunderink has received an investigator-initiated grant, participated in a clinical trial, and is a member of a data safety monitoring board with unrelated compounds/diagnostic tests for Pfizer".
PY - 2013/8/1
Y1 - 2013/8/1
N2 - Community associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is an emerging threat to human health throughout the world. Rodent MRSA pneumonia models mainly focus on the early innate immune responses to MRSA lung infection. However, the molecular pattern and mechanisms of recovery from MRSA lung infection are largely unknown. In this study, a sublethal mouse MRSA pneumonia model was employed to investigate late events during the recovery from MRSA lung infection. We compared lung bacterial clearance, bronchoalveolar lavage fluid (BALF) characterization, lung histology, lung cell proliferation, lung vascular permeability and lung gene expression profiling between days 1 and 3 post MRSA lung infection. Compared to day 1 post infection, bacterial colony counts, BALF total cell number and BALF protein concentration significantly decreased at day 3 post infection. Lung cDNA microarray analysis identified 47 significantly up-regulated and 35 down-regulated genes (p<0.01, 1.5 fold change [up and down]). The pattern of gene expression suggests that lung recovery is characterized by enhanced cell division, vascularization, wound healing and adjustment of host adaptive immune responses. Proliferation assay by PCNA staining further confirmed that at day 3 lungs have significantly higher cell proliferation than at day 1. Furthermore, at day 3 lungs displayed significantly lower levels of vascular permeability to albumin, compared to day 1. Collectively, this data helps us elucidate the molecular mechanisms of the recovery after MRSA lung infection.
AB - Community associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is an emerging threat to human health throughout the world. Rodent MRSA pneumonia models mainly focus on the early innate immune responses to MRSA lung infection. However, the molecular pattern and mechanisms of recovery from MRSA lung infection are largely unknown. In this study, a sublethal mouse MRSA pneumonia model was employed to investigate late events during the recovery from MRSA lung infection. We compared lung bacterial clearance, bronchoalveolar lavage fluid (BALF) characterization, lung histology, lung cell proliferation, lung vascular permeability and lung gene expression profiling between days 1 and 3 post MRSA lung infection. Compared to day 1 post infection, bacterial colony counts, BALF total cell number and BALF protein concentration significantly decreased at day 3 post infection. Lung cDNA microarray analysis identified 47 significantly up-regulated and 35 down-regulated genes (p<0.01, 1.5 fold change [up and down]). The pattern of gene expression suggests that lung recovery is characterized by enhanced cell division, vascularization, wound healing and adjustment of host adaptive immune responses. Proliferation assay by PCNA staining further confirmed that at day 3 lungs have significantly higher cell proliferation than at day 1. Furthermore, at day 3 lungs displayed significantly lower levels of vascular permeability to albumin, compared to day 1. Collectively, this data helps us elucidate the molecular mechanisms of the recovery after MRSA lung infection.
UR - http://www.scopus.com/inward/record.url?scp=84880992269&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0070176
DO - 10.1371/journal.pone.0070176
M3 - Article
C2 - 23936388
AN - SCOPUS:84880992269
SN - 1932-6203
VL - 8
JO - PloS one
JF - PloS one
IS - 8
M1 - e70176
ER -